2/27/23
Greetings Readers,
It’s Monday which means I don’t want to take up too much of your time.
My last profile, (ATNM), was a solid double-digit, short term champ.
Running approximately $1.00+ (11%) from a Tuesday 2/14 open to its Tuesday 2/21 high, it joined the long list of champs I’ve delivered over the last several months.
And don’t forget, if you were with us for when I brought ATNM to your attention the morning of October 24th, it has now maxed out a run of approximately 101% to this past Tuesday’s high.
Plus, let me give you another reminder of how hot we’ve been by talking about our recent profile (HILS).
Running from a January 30th, $.596 open, to a February high of $2.65, its $2.00+ surge meant an approximate 344% in under 2 weeks.
But those ideas could just be the tip of the iceberg.
At 8:00PM EST tonight, I’ve got a new Nasdaq Biopharma idea to bring to your immediate attention.
Before the complete report arrives, here’s a few key details to soak in.
No. 1: Yahoo Finance is reporting a low float of fewer than 10Mn shares. This means volatility could be in the cards on a daily basis.
No. 2: Barchart is reporting over 10 different triggered technical indicators across the short, medium, and long term as of 11:00AM EST Monday.
No. 3: A massive analyst target from Maxim Group provides over 140% potential upside for this Nasdaq profile from its Monday 11:00AM EST valuation.
Clear your schedule now and be on the lookout for the full report tonight at 8:00PM EST.
Sincerely,
Virtus Junxit
